share_log

完美醫療：發行及購回股份的一般授權、擴大發行股份的一般授權、重選退任董事及股東週年大會通告

PERFECT MEDICAL: GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES,EXTENSION OF GENERAL MANDATE TO ISSUE SHARES,RE-ELECTION OF RETIRING DIRECTORS, AND NOTICE OF ANNUAL GENERAL MEETING

HKEX ·  Jul 16 16:35

Summary by Futu AI

完美醫療健康管理有限公司（「本公司」）將於2024年8月9日舉行股東週年大會，地點為香港九龍旺角康得思酒店。會議將討論包括發行及購回股份的一般授權、擴大發行股份的一般授權、重選退任董事等議題。股東將審議是否授予董事發行不超過已發行股份總數20%的股份的權力，以及購回不超過10%的股份。此外，將重選四名獨立非執行董事，包括徐慧敏女士、季志雄先生、曹依萍女士及戚世昌先生。股東週年大會通告詳情載於公司通函第17至21頁。公司強調，無論股東能否出席會議，都應盡早填妥並提交代表委任表格。公司將於2024年8月6日至9日暫停股份過戶登記。
完美醫療健康管理有限公司（「本公司」）將於2024年8月9日舉行股東週年大會，地點為香港九龍旺角康得思酒店。會議將討論包括發行及購回股份的一般授權、擴大發行股份的一般授權、重選退任董事等議題。股東將審議是否授予董事發行不超過已發行股份總數20%的股份的權力，以及購回不超過10%的股份。此外，將重選四名獨立非執行董事，包括徐慧敏女士、季志雄先生、曹依萍女士及戚世昌先生。股東週年大會通告詳情載於公司通函第17至21頁。公司強調，無論股東能否出席會議，都應盡早填妥並提交代表委任表格。公司將於2024年8月6日至9日暫停股份過戶登記。
Perfect Medical Health Management Limited ("the Company") will hold its annual shareholder meeting on August 9, 2024, at the Cordis Hotel in Mong Kok, Hong Kong. The meeting will discuss issues including the general authorization for the issuance and repurchase of shares, the general authorization for the expansion of share issuance, and the re-election and resignation of directors. Shareholders will consider whether to authorize directors to issue up to 20% of the total issued shares and buy back up to 10% of the shares. In addition, four independent non-executive directors, including Ms. Henny Hui Min Hsu, Mr. Chi Hung Kai, Ms. Yiping Cao, and Mr. Shichang Qi, will be re-elected. Details of the shareholder meeting are included in the Company's circular from pages 17 to 21. The Company emphasizes that whether shareholders can attend the meeting or not, they should fill out and submit the appointment of proxy form as soon as possible. The company's share transfer registration will be suspended from August 6 to 9, 2024.
Perfect Medical Health Management Limited ("the Company") will hold its annual shareholder meeting on August 9, 2024, at the Cordis Hotel in Mong Kok, Hong Kong. The meeting will discuss issues including the general authorization for the issuance and repurchase of shares, the general authorization for the expansion of share issuance, and the re-election and resignation of directors. Shareholders will consider whether to authorize directors to issue up to 20% of the total issued shares and buy back up to 10% of the shares. In addition, four independent non-executive directors, including Ms. Henny Hui Min Hsu, Mr. Chi Hung Kai, Ms. Yiping Cao, and Mr. Shichang Qi, will be re-elected. Details of the shareholder meeting are included in the Company's circular from pages 17 to 21. The Company emphasizes that whether shareholders can attend the meeting or not, they should fill out and submit the appointment of proxy form as soon as possible. The company's share transfer registration will be suspended from August 6 to 9, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated